Area of research
Hepatology · Epidemiology
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, and Liver Disease and Transplantation.
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe
CHOLANGIOCARCINOMA IN INDIVIDUALS WITH CHRONIC LIVER DISEASE IS DIAGNOSED EARLIER, LEADING TO BETTER PROGNOSIS
87P Clinical characteristics and outcomes of patients with cholangiocarcinoma (CCA) undergoing liver transplantation (LT): An observational study from the ENSCCA registry
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma
Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry
Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Resected Perihilar Cholangiocarcinoma, the ENS-CCA Registry
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
Presentation, Management and Outcome of Cholangiocarcinoma in Europe: Results From Real-World Patient Registry
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
Consensus Report of the Fifth International Forum for Liver MRI
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design